|View printer-friendly version|
|Array BioPharma to Present at the Morgan Stanley Global Healthcare Unplugged Conference and the Baird Small Cap Healthcare Conference|
BOULDER, Colo.--(BUSINESS WIRE)--Sept. 2, 2008--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Morgan Stanley Global Healthcare Unplugged Conference on September 9 and the Baird Small Cap Healthcare Conference on September 10 in New York City. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website.
Event: Morgan Stanley Global Healthcare Unplugged
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory diseases and pain. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Array BioPharma Inc.